Stephania cepharantha-derived alkaloid-containing preparation
AssigneesJapan AS Represented By Director-General of National Institute of Infectious Diseases, Sawai Pharmaceutical Co., Ltd.
InventorsKoichi WATASHI, Wakana SASO, Toru TERASHIMA
Life of this patent
Estimating the term…
Abstract
In an embodiment, a Stephania cepharantha-derived alkaloid-containing preparation for treatment of a novel coronavirus infection is provided. According to an embodiment of the present invention, a preparation for treatment of a novel coronavirus infection comprises Cepharanthine, Isotetrandrine, Cycleanine, and Berbamine. A preparation for treatment of a novel coronavirus infection is for treatment of an infection caused by the novel coronavirus mutant strain. According to an embodiment of the present invention, a Stephania cepharantha-derived alkaloid-containing preparation for treatment of a novel coronavirus infection is provided.
Claims10
A method for treatment of a novel coronavirus infection comprising:
- administering a Stephania cepharantha-derived alkaloid-containing preparation including Cepharanthine, Isotetrandrine, Cycleanine, and Berbamine to a patient.
Dependencies are inferred from the claim text.